In addition, STK11 mutations are associated with a reduced density of tumor-infiltrating cytotoxic CD8+ T lymphocytes and an increase in pro-inflammatory cytokine production, leading to a more immunosuppressive tumor microenvironment [13]. The gene discussed is CD8A; the disease is neoplasm.